| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 04/15/2004 | WO2004005289A3 Efficient synthesis of pyropheophorbide a and its derivatives |
| 04/15/2004 | WO2003045324A3 14-methyl-epothilones |
| 04/15/2004 | WO2002083111A3 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
| 04/15/2004 | US20040073054 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups |
| 04/15/2004 | US20040073026 Cyclic protein tyrosine kinase inhibitors |
| 04/15/2004 | US20040072889 Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia |
| 04/15/2004 | US20040072871 Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them |
| 04/15/2004 | US20040072860 Piperazin-2-one amides as inhibitors of factor xa |
| 04/15/2004 | US20040072856 Antitumor agents, anticancer agents |
| 04/15/2004 | US20040072849 Dioxanes and uses thereof |
| 04/15/2004 | US20040072847 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders |
| 04/15/2004 | US20040072833 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/15/2004 | US20040072830 Squalene synthetase inhibitors; antilipemic agents; antiischemic agents; cardiovascular disorders; anticholesterol agents |
| 04/15/2004 | US20040072819 Benzoxazepine compounds, their production and use |
| 04/15/2004 | US20040072818 Antiinflammatory agents; autoimmune disease; anticancer agents |
| 04/15/2004 | US20040072209 Methods of labelling polynucleotides with dibenzorhodamine dyes |
| 04/15/2004 | DE19744257B4 Beta-Carboline und deren Verwendung zur Behandlung von malignen und anderen, auf pathologischen Zellproliferationen beruhenden Erkrankungen Beta-carbolines and their use for the treatment of malignant and other diseases based on pathological cell proliferations |
| 04/15/2004 | DE10046215B4 Fluorochrome und deren Verwendung Fluorochromes and their use |
| 04/15/2004 | DE10012825B4 Verfahren zur Herstellung von spirocyclischen Tetronsäurederivaten Process for the preparation of spirocyclic Tetronsäurederivaten |
| 04/15/2004 | CA2500822A1 Nodulisporic acid derivative spot-on formulations for combating parasites |
| 04/15/2004 | CA2500815A1 Method and intermedia used to obtain derivatives of 1-(1h-benzimidazole-2-il)-4-(2-aminopyrimidine)piperidine |
| 04/14/2004 | EP1408090A1 Dibenzorhodamine dyes useful as fluorescent labelling agents |
| 04/14/2004 | EP1408041A1 Process for preparation of amidine derivatives |
| 04/14/2004 | EP1408040A1 Tricyclic fused heterocyclic compounds as CRFantagonists |
| 04/14/2004 | EP1406901A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 04/14/2004 | EP1406891A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 04/14/2004 | EP1406630A1 Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 04/14/2004 | EP1202994B1 New compounds |
| 04/14/2004 | EP1115708B1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 04/14/2004 | EP1073655B1 Pharmaceutically available protoberberine salts derivatives, and protoberberine derivatives and salts thereof |
| 04/14/2004 | EP0839149B1 Galanthamine derivatives, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
| 04/14/2004 | CN1488631A Cyclic-aliphatic epoxy compound containing pheneylethylene cinnamyl or maleimide functional group |
| 04/13/2004 | US6720346 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation |
| 04/13/2004 | US6720329 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) |
| 04/13/2004 | US6720324 Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof |
| 04/13/2004 | US6720320 Phenoxypropylamine compounds |
| 04/13/2004 | US6719925 Photochromism; ophthalmic lenses |
| 04/13/2004 | US6719540 C3-cyano epothilone derivatives |
| 04/08/2004 | WO2004029579A2 Fluorescent labeling reagents with multiple donors and acceptors |
| 04/08/2004 | WO2004029578A2 Energy transfer dyes, terminators and use thereof |
| 04/08/2004 | WO2004028452A2 Method for preparing crambescidin core acid intermediates and their use for preparing crambescidin alkaloid analogs as therapeutic agents |
| 04/08/2004 | WO2004028445A2 Processes for preparing 1,3-dioxolane nucleosides |
| 04/08/2004 | WO2004017961A3 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 04/08/2004 | WO2004014361A9 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 04/08/2004 | WO2004014150A9 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 04/08/2004 | WO2003098617B1 Optical storage media comprising pentacyclic xanthylium dyes |
| 04/08/2004 | WO2003095459A3 Alkaloid-derived compounds and use thereof in cancer and malaria treatment |
| 04/08/2004 | US20040068114 Rylene derivatives |
| 04/08/2004 | US20040067990 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 04/08/2004 | US20040067989 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents |
| 04/08/2004 | US20040067974 Alzheimer's disease; Down's syndrome; synergistic mixture containing galanthamine |
| 04/08/2004 | US20040067959 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 04/08/2004 | US20040067945 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 04/08/2004 | US20040067944 Antiarrhythmia agents |
| 04/08/2004 | US20040067914 R-NSAID esters and their use |
| 04/07/2004 | EP1404679A2 (hetero)aryl substituted benzofurans as 5-ht ligands |
| 04/07/2004 | EP1404438A2 A surfactant assisted nanomaterial generation process |
| 04/07/2004 | EP1404341A1 Active substance combination for medicamentous therapy of nicotine dependency |
| 04/07/2004 | EP1404337A2 QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 04/07/2004 | EP1404333A1 Oxymorphone controlled release formulations |
| 04/07/2004 | EP0894799B1 Indolomorphinane derivatives and remedies/preventives for cerebral disorders |
| 04/07/2004 | CN1487942A Hexahydropyrrolo [1,2-c] pyrimidines as antiviral, antifungal and/or antitumor agents |
| 04/07/2004 | CN1487940A Lactam compounds and medicinal use thereof |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1487920A Deltal-pyrrolines used as pesticides |
| 04/07/2004 | CN1144793C Polar-substituted hydrocarbons |
| 04/07/2004 | CN1144786C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 04/07/2004 | CN1144587C Agents for relieving side effects |
| 04/06/2004 | US6716992 Free radical curable; adhesives |
| 04/06/2004 | US6716983 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof |
| 04/06/2004 | US6716982 Introducing chirality at position 20 as penultimate step reduces waste, cost of materials handling and risk of contamination; chemical intermediates |
| 04/06/2004 | US6716979 Including coumarins, rhodamines, and rhodols that incorporate additional fused aromatic rings; absorb at a longer wavelength than structurally similar dyes that do not possess the fused aromatic rings; dye conjugates; reactive dyes |
| 04/06/2004 | US6716846 High affinity ligands for nociceptin receptor ORL-1 |
| 04/06/2004 | US6716832 Arylphenyl-substituted cyclic ketoenols |
| 04/06/2004 | US6716828 Treatment or prevention of neural or cardiovascular tissue damage related to cerebral ischemia and reperfusion injury in an animal by administering poly(adp- ribose) polymerase (?parp?) inhibitors. |
| 04/01/2004 | WO2004026878A1 6,7-DIHYDRO-5H-PYRAZOLO[1,2-a]PYRAZOL-1-ONES WHICH CONTROL INFLAMMATORY CYTOKINES |
| 04/01/2004 | WO2004026864A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 04/01/2004 | WO2004026855A1 Method for manufacture of dihydroisobenzofuran derivatives |
| 04/01/2004 | WO2004026819A2 OPIATE ANALOGS SELECTIVE FOR THE delta-OPIOID RECEPTOR |
| 04/01/2004 | WO2003080596A3 Bicyclic fused pyridinyl amides and advantageous compositions thereof for use as fungicides |
| 04/01/2004 | WO2003008410A8 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 04/01/2004 | WO2002102314A3 Purine inhibitors of phosphodiesterase (pde) 7 |
| 04/01/2004 | WO2002076402A3 Fatty amine drug conjugates |
| 04/01/2004 | US20040063973 Process for preparing kifunensine intermediate and kifunensine therefrom |
| 04/01/2004 | US20040063947 Cyclization; antitumor agents |
| 04/01/2004 | US20040063935 Aliphatic nitrogenous five-membered ring compounds |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063740 Nitrogen-based homo-camptothecin derivatives |
| 04/01/2004 | US20040063735 Calcitonin gene related peptide receptor antagonists |
| 04/01/2004 | US20040063720 Tyrosine kinase inhibitors |
| 04/01/2004 | US20040063713 Such as 2-((4-(2-fluorophenyl)-1-piperazinyl)methyl)-1H-thieno(3,4-d)imidazole |
| 04/01/2004 | US20040063702 Benzo[b]pyrano[3,2-h]acridin-7-one compounds |
| 04/01/2004 | US20040063675 Synthesis of pancrastistatin |
| 04/01/2004 | US20040062713 Dye; photosensitive stimulant; using eye |
| 04/01/2004 | CA2499326A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 04/01/2004 | CA2498046A1 Opiate analogs selective for the delta-opioid receptor |
| 04/01/2004 | CA2496500A1 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 03/31/2004 | EP1403256A1 Fused imidazole derivative |
| 03/31/2004 | EP1401839A1 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta a]naphthalene |
| 03/31/2004 | EP1401831A1 Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors |